Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
02/2008
02/14/2008WO2008019053A2 Process for preparing clopidogrel bisulphate
02/14/2008WO2008018881A1 6,6-bicyclic ring substituted sulfur containing heterobicyclic protein kinase inhibitors
02/14/2008WO2008018779A1 Process for high yield production of clopidogrel by racemization of residual liquid
02/14/2008WO2008017594A1 Thieno[3,2-c]pyridine-7-carboxylic acid derivatives
02/14/2008WO2008005954A3 Tryphostin-analogs for the treatment of cell proliferative diseases
02/14/2008WO2007117381A3 2 -aminopyridine analogs as glucokinase activators
02/14/2008US20080039511 Thiazole Compound and Use Thereof
02/14/2008US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease
02/14/2008US20080039447 CDK-Inhibitory pyrimidines, their production and use as pharmaceutical agents
02/14/2008US20080039446 Substituted isoindoles and their use
02/14/2008US20080038745 Nucleotide analogs with six-membered rings
02/14/2008US20080038191 Radiolabeled Compounds And Compositions, Their Precursors And Methods For Their Production
02/14/2008CA2658285A1 Thieno[3,2-c]pyridine-7-carboxylic acid derivatives for use in treating solid tumors
02/14/2008CA2655844A1 Process for preparing clopidogrel bisulphate
02/13/2008EP1887008A1 Thienotriazolodiazepine compound and a medicinal use thereof
02/13/2008EP1886999A2 Bicyclic heteroaromatic compound
02/13/2008EP1885715A1 Selected tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
02/13/2008CN101124231A Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
02/13/2008CN101124229A Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders
02/13/2008CN101124201A Parp抑制剂 Parp inhibitors
02/13/2008CN101121720A Method for preparing clopidogrel hydrogen shlfate
02/12/2008US7329896 Polymerizable charge transport compounds
02/12/2008US7329765 Benzothiophene compounds having antiinfective activity
02/12/2008US7329751 Process for the preparation of clopidogrel
02/12/2008US7329747 Synthesis of olanzapine and intermediates thereof
02/12/2008US7329653 (4-cyclohexyl-phenyl)-(4H, 10H-3a,5,9-triaza-benzo[f]azulen-9-yl)-methanone; antidiuretic, anticoagulant, diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, delay of urination, or bleeding
02/12/2008CA2315261C Oral pharmaceutical extended release dosage form
02/12/2008CA2227695C Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission
02/07/2008WO2008016187A1 Pladienolide target molecule, compound capable of binding to the target molecule, and screening method for the compound
02/07/2008WO2007146758A3 Novel mch receptor antagonists
02/07/2008WO2007109596A3 Heteroaryl dihydroindolones as kinase inhibitors
02/07/2008US20080033175 Process for preparation of 4-amino-3-quinolinecarbonitriles
02/07/2008US20080032417 Photocleavable isotope-coded affinity tags
02/07/2008US20080032288 Labeling Reagents, Methods for the Synthesis of Such Reagents and Methods for the Detection of Biological Molecules
02/07/2008DE10361713B4 Verwendung von Charge-Transfer-Komplexen aus einem Elektronendonor und einem Elektronenakzeptor als Basis für resistive Speicher und Speicherzelle enthaltend diese Komplexe Use of charge-transfer complexes made of an electron donor and an electron acceptor as the basis for memory and resistive memory cell comprising these complexes
02/06/2008CN101120003A Thieno-pyridine derivatives as GABA-B allosteric enhancers
02/06/2008CN100366623C Light-emitting device, condensed polycyclic compound used therein and method for producing same
02/05/2008US7326793 From a pyrrolidinone compound; coloring high molecular weight material
02/05/2008US7326791 Carboxylic acid amides, the preparation thereof, and their use as pharmaceutical compositions
02/05/2008US7326785 Preparation of 3-(thienylalkenylenesulfonylamino)-1-(4--morpholinylcarbonyl-alpha-substituted methyl)pyrrolidone derivatives: 2-(5-Chlorothien-2-yl)-N-methyl-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide
02/05/2008US7326714 6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
02/05/2008US7326713 Such as aurora-2 kinase or c-kit kinase; anticancer agents; based on benzo(4,5)furo(3,2-d)pyrimidine, 9-thia-1,5,7-triazafluorene, or pyrimido(5,4-b)indole rings; e.g. 6,7-dimethoxy-4-(4-(benzodioxol-5-ylmethylaminothiocarbonyl)-piperazin-1-yl)-5H-Pyrimido(5,4-b)indole
02/05/2008US7326712 Substituted tricyclic compounds as protein kinase inhibitors
02/05/2008US7326705 2-amino or carbonylamino-4-carbocyclic imidazoles and thiazoles; antiischemic agents, hypotensive agents, antiarrhythmia agents; can be coadministered with other drugs
01/2008
01/31/2008WO2008011957A1 Substituted benzodithiophenes and benzodiselenophenes
01/31/2008US20080027228 Substituted thioacetamides
01/31/2008US20080027050 Heterocyclic Amide Compound and Use Thereof as an Mmp-13 Inhibitor(Amended Ex Officio)
01/31/2008US20080027029 Cold menthol receptor-1 antagonists
01/31/2008CA2658821A1 Pyridizinone derivatives and uses thereof to treat diseases, disorders and/or conditions that may be mediated or modulated by inhibition of h3 receptors
01/30/2008EP1881989A1 Thienopyrroles as antiviral agents
01/30/2008EP1881988A1 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones modulating the function of the vanilloid-1 receptor (vr1)
01/30/2008EP1881976A1 Substituted amide derivatives as protein kinase inhibitors
01/30/2008CN100364973C Indolone-acetamide derivatives, processes for preparing them and their uses
01/30/2008CN100364971C Pyrrolidine-2-ones as factor Xa inhibitors
01/29/2008US7323487 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
01/29/2008US7323486 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
01/29/2008US7323473 Administering (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C) for treatment of obesity
01/29/2008US7323459 Dissolving olanzapine in a solution of acetic acid and water; filtering the solution; stirring the solution; precipitating the crystalline form by adding a base; and isolating the crystals
01/29/2008US7323458 Dihydrobenzodiazepins and their use for treating dyslipidemia
01/24/2008WO2008011521A2 Polycyclic viral inhibitors
01/24/2008WO2008011337A1 Hcv inhibitors
01/24/2008WO2007136776A3 Pyrimidine low molecular weight ligands for modulating hormone receptors
01/24/2008WO2007136668A3 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
01/24/2008WO2007129161A3 Thieno [3, 2-d] pyrimidine derivative useful as pi3k inhibitor
01/24/2008US20080021201 Protease inhibitor conjugates and antibodies useful in immunoassay
01/24/2008DE102007032613A1 Spiraprilhydrochlorid und polymorphe Formen davon Spirapril hydrochloride and polymorphic forms thereof
01/24/2008CA2657788A1 Polycyclic viral inhibitors
01/23/2008EP1879899A1 Thienopyridine derivatives as potassium channel inhibitors
01/23/2008EP1879892A2 2-pyrrolidone derivatives and their uses for the treatment of inflammatory conditions and pain
01/23/2008EP1879886A1 Mitotic kinesin inhibitors and methods of use thereof
01/23/2008EP1768985B1 Pyrimido-benzimidazole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors
01/23/2008EP1711825A4 Conjugated small molecules
01/23/2008EP1667635A4 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors
01/23/2008EP1322651B1 Bicyclic heteroaromatic compounds
01/23/2008EP1322619B1 Isoquinolinone potassium channel inhibitors
01/23/2008CN101111497A Fused thiophenes, methods for making fused thiophenes, and uses thereof
01/23/2008CN100363348C PgD2 receptor antagonists for the treatment of inflammatory diseases
01/22/2008US7320993 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic useful as cytostatic and immuosuppressive agents
01/17/2008WO2008008912A1 Antiviral agents
01/17/2008US20080015352 zinc complexed with triiodothyronine; improved potency, stability, absorbability, targeted delivery
01/17/2008US20080015215 Diamine derivatives
01/17/2008US20080015179 such as ethyl 3-(1'-methyl-2'-oxospiro[cyclohexane-1,3'-indoline]-4-yl)-8-azabicyclo[3.2.1]octane-8-carboxylate, used for the treatment of nervous system disorders, psychological disorders, autoimmune diseases, gastrointestinal disorders, vision defects, obesity and cardiovascular disorders
01/17/2008US20080014189 Diaminotriazoles useful as inhibitors of protein kinases
01/17/2008CA2657651A1 Antiviral agents
01/16/2008EP1622889A4 Pesticidal (dihalopropenyl)phenylalkyl substituted benzodioxolane and benzodioxole derivatives
01/16/2008EP1532154B1 Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone
01/16/2008EP1458784B1 3,4-alkylenedioxythiophene compounds and polymers thereof
01/16/2008EP0977754B1 Writable and erasable high-density optical storage media
01/16/2008CN101107254A Heterocyclic tetracyclic tetrahydrofuran derivatives as 5ht2 inhibitors in the treatment of cns disorders
01/16/2008CN101107253A Mitotic kinesin inhibitors
01/16/2008CN101104619A Decarboxylation preparation technique for ethylene dioxythiophene
01/10/2008WO2008006039A1 Dihydrothieno pyrimidines as akt protein kinase inhibitors
01/10/2008WO2008005954A2 Tryphostin-analogs for the treatment of cell proliferative diseases
01/10/2008WO2008004249A2 An improved process for the preparation of clopidogrel and its pharmaceutically acceptable salts
01/10/2008WO2008004117A1 Selective azole pde10a inhibitor compounds
01/10/2008WO2008004033A1 A stable olanzapine formulation with antioxidants
01/10/2008WO2008003452A1 Pyrazolealkanamide substituted thiophenes as ampa potentiators
01/10/2008WO2007117995A3 Kinase inhibitors
01/10/2008US20080009531 5-Anilino-4-Heteroarylpyrazole Derivatives Useful for the Treatment of Diabetes
01/10/2008US20080008720 Substituted Tricyclic Heterocycles and their Uses
1 ... 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 ... 214